Marked antitumor effect of NK012, a SN-38-incorporating micelle formulation, in a newly developed mouse model of liver metastasis resulting from gastric cancer
![Marked antitumor effect of NK012, a SN-38-incorporating micelle formulation, in a newly developed mouse model of liver metastasis resulting from gastric cancer](https://www.future-science.com/cms/10.4155/tde.13.143/asset/images/medium/figure2.gif)
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs43018-023-00686-w/MediaObjects/43018_2023_686_Fig5_HTML.png)
Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease
![](https://www.mdpi.com/ijms/ijms-23-11662/article_deploy/html/images/ijms-23-11662-g001.png)
IJMS, Free Full-Text
![](https://www.dovepress.com/getfile_article_fulltext.php?filename=article_fulltext%2Fs158000%2F158426/img/IJN-158426-F05.jpg)
SN38-loaded 100 nm targeted liposomes for improving poor solubility an
![](https://ars.els-cdn.com/content/image/1-s2.0-S0169409X10001353-gr4.jpg)
Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect - ScienceDirect
![](https://www.mdpi.com/pharmaceutics/pharmaceutics-15-00976/article_deploy/html/images/pharmaceutics-15-00976-g001-550.jpg)
Pharmaceutics, Free Full-Text
![](https://www.frontiersin.org/files/Articles/772920/fonc-11-772920-HTML/image_m/fonc-11-772920-g001.jpg)
Frontiers Nano-Delivery of a Novel Inhibitor of Polynucleotide Kinase/Phosphatase (PNKP) for Targeted Sensitization of Colorectal Cancer to Radiation-Induced DNA Damage
![](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-12-01033/article_deploy/html/images/pharmaceutics-12-01033-g006.png?1603968095)
Pharmaceutics, Free Full-Text
![](https://www.future-science.com/cms/10.4155/tde.2014.5.issue-2/asset/17b34440-b117-3444-cb11-b34440cb117b/cover.jpg)
Marked antitumor effect of NK012, a SN-38-incorporating micelle formulation, in a newly developed mouse model of liver metastasis resulting from gastric cancer
Improving the Therapeutic Index in Cancer Therapy by Using Antibody–Drug Conjugates Designed with a Moderately Cytotoxic Drug
![](https://pub.mdpi-res.com/micromachines/micromachines-13-01623/article_deploy/html/images/micromachines-13-01623-g006.png?1666175213)
Micromachines, Free Full-Text